These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16216019)

  • 1. Multidimensional effects of sertraline in social anxiety disorder.
    Connor KM; Davidson JR; Chung H; Yang R; Clary CM
    Depress Anxiety; 2006; 23(1):6-10. PubMed ID: 16216019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie YJ; Nandy S; Pecknold JC; Hadrava V; Lane RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
    Liebowitz MR; DeMartinis NA; Weihs K; Londborg PD; Smith WT; Chung H; Fayyad R; Clary CM
    J Clin Psychiatry; 2003 Jul; 64(7):785-92. PubMed ID: 12934979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia.
    Phan KL; Coccaro EF; Angstadt M; Kreger KJ; Mayberg HS; Liberzon I; Stein MB
    Biol Psychiatry; 2013 Feb; 73(4):329-36. PubMed ID: 23164370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline for social phobia: a double-blind, placebo-controlled crossover study.
    Katzelnick DJ; Kobak KA; Greist JH; Jefferson JW; Mantle JM; Serlin RC
    Am J Psychiatry; 1995 Sep; 152(9):1368-71. PubMed ID: 7653696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
    Huang X; Li C; Li WH; Luo YL; Wang B; Zhang W; Gan JJ; Ji JL
    Hum Psychopharmacol; 2013 Nov; 28(6):594-9. PubMed ID: 24519693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label treatment with escitalopram in patients with social anxiety disorder and fear of blushing.
    Pelissolo A; Moukheiber A
    J Clin Psychopharmacol; 2013 Oct; 33(5):695-8. PubMed ID: 23948787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline in social phobia.
    Munjack DJ; Flowers C; Eagan TV
    Anxiety; 1994-1995; 1(4):196-8. PubMed ID: 9160574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Have no fear: the neural basis of anxiolytic drug action in generalized social phobia.
    Harmer CJ
    Biol Psychiatry; 2013 Feb; 73(4):300-1. PubMed ID: 23351889
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
    J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
    Schneier FR; Campeas R; Carcamo J; Glass A; Lewis-Fernandez R; Neria Y; Sanchez-Lacay A; Vermes D; Wall MM
    Depress Anxiety; 2015 Aug; 32(8):570-9. PubMed ID: 26115513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors.
    Dahl AA; Ravindran A; Allgulander C; Kutcher SP; Austin C; Burt T
    Acta Psychiatr Scand; 2005 Jun; 111(6):429-35. PubMed ID: 15877709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline in the treatment of anxiety disorders.
    Hirschfeld RM
    Depress Anxiety; 2000; 11(4):139-57. PubMed ID: 10945134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
    Rickels K; Mangano R; Khan A
    J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.